129 related articles for article (PubMed ID: 37074845)
1. Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations.
Cornejo KM; Hutchinson L; O'Donnell P; Meng X; Tomaszewicz K; Shalin SC; Cassarino DS; Chan MP; Quinn TR; Googe PB; Nazarian RM
Arch Pathol Lab Med; 2024 Feb; 148(2):215-222. PubMed ID: 37074845
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma arising from a syringocystadenoma papilliferum in a nevus sebaceus of Jadassohn.
Hügel H; Requena L
Am J Dermatopathol; 2003 Dec; 25(6):490-3. PubMed ID: 14631190
[TBL] [Abstract][Full Text] [Related]
3. Syringocystadenoma Papilliferum of the Anogenital Area and Buttocks: A Report of 16 Cases, Including Human Papillomavirus Analysis and HRAS and BRAF V600 Mutation Studies.
Konstantinova AM; Kyrpychova L; Nemcova J; Sedivcova M; Bisceglia M; Kutzner H; Zamecnik M; Sehnalkova E; Pavlovsky M; Zateckova K; Shvernik S; Spurkova Z; Michal M; Kerl K; Kazakov DV
Am J Dermatopathol; 2019 Apr; 41(4):281-285. PubMed ID: 30398985
[TBL] [Abstract][Full Text] [Related]
4. Nevus Sebaceous of the Scalp With Stepwise Progression Into Invasive Syringocystadenocarcinoma Papilliferum.
Kneitz H; Goebeler M; Rütten A
Am J Dermatopathol; 2021 Dec; 43(12):965-969. PubMed ID: 34797792
[TBL] [Abstract][Full Text] [Related]
5. Activating mutations in the RAS/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum.
Shen AS; Peterhof E; Kind P; Rütten A; Zelger B; Landthaler M; Berneburg M; Hafner C; Groesser L
Hum Pathol; 2015 Feb; 46(2):272-6. PubMed ID: 25532942
[TBL] [Abstract][Full Text] [Related]
6. Syringocystadenocarcinoma papilliferum in a linear nevus verrucosus.
Hoekzema R; Leenarts MF; Nijhuis EW
J Cutan Pathol; 2011 Feb; 38(2):246-50. PubMed ID: 19758371
[TBL] [Abstract][Full Text] [Related]
7. Morphologic diversity of syringocystadenocarcinoma papilliferum based on a clinicopathologic study of 6 cases and review of the literature.
Kazakov DV; Requena L; Kutzner H; Fernandez-Figueras MT; Kacerovska D; Mentzel T; Schwabbauer P; Michal M
Am J Dermatopathol; 2010 Jun; 32(4):340-7. PubMed ID: 20216201
[TBL] [Abstract][Full Text] [Related]
8. Complex sweat gland hamartoma: A case report.
Skopec Z; Berrebi KG; Stone M; Liu V
J Cutan Pathol; 2023 Mar; 50(3):243-246. PubMed ID: 36323653
[TBL] [Abstract][Full Text] [Related]
9. Syringocystadenocarcinoma papilliferum with locoregional metastases.
Satter E; Grady D; Schlocker CT
Dermatol Online J; 2014 Apr; 20(4):22335. PubMed ID: 24746298
[TBL] [Abstract][Full Text] [Related]
10. Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a nevus sebaceus.
Miller CJ; Ioffreda MD; Billingsley EM
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1546-9. PubMed ID: 15606837
[TBL] [Abstract][Full Text] [Related]
11. A Histological Snapshot of Hypothetical Multistep Progression From Nevus Sebaceus to Invasive Syringocystadenocarcinoma Papilliferum.
Parekh V; Guerrero CE; Knapp CF; Elmets CA; McKay KM
Am J Dermatopathol; 2016 Jan; 38(1):56-62. PubMed ID: 26317389
[TBL] [Abstract][Full Text] [Related]
12. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
[TBL] [Abstract][Full Text] [Related]
13. Another view regarding ductal carcinoma arising from a syringocystadenoma papilliferum in a nevus sebaceus of Jadassohn: can a dermal component of syringocystadenoma papilliferum be excluded with certainty?
Resnik KS
Am J Dermatopathol; 2003 Dec; 25(6):494-5; discussion 496. PubMed ID: 14631191
[No Abstract] [Full Text] [Related]
14. Syringocystadenocarcinoma papilliferum with squamous cell carcinoma differentiation and with locoregional metastasis.
Arslan H; Diyarbakrl M; Batur S; Demirkesen C
J Craniofac Surg; 2013 Jan; 24(1):e38-40. PubMed ID: 23348331
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma and syringocystadenoma papilliferum arising in nevus sebaceus.
Findik H; Ciloğlu NS; Uzunismail A
Plast Reconstr Surg; 2006 Jan; 117(1):320-1. PubMed ID: 16404295
[No Abstract] [Full Text] [Related]
16. Linear syringocystadenoma papilliferum on the retroauricular area associated with nevus sebaceus.
Ekinci AP; Buyukbabani N; Mehdi L; Yazganoglu KD; Baykal C
Dermatol Online J; 2016 Nov; 22(11):. PubMed ID: 28329571
[TBL] [Abstract][Full Text] [Related]
17. Syringocystadenocarcinoma papilliferum: Clinicopathologic analysis of 10 cases.
Zhang Y; Kong YY; Cai X; Shen XX; Kong JC
J Cutan Pathol; 2017 Jun; 44(6):538-543. PubMed ID: 28337777
[TBL] [Abstract][Full Text] [Related]
18. A rare case of syringocystadenocarcinoma papilliferum of the breast: An institutional retrospective case review and brief literature review.
McBride JD; Billings SD; Komforti MK
J Cutan Pathol; 2021 Nov; 48(11):1387-1391. PubMed ID: 34089523
[TBL] [Abstract][Full Text] [Related]
19. Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis.
Peterson J; Tefft K; Blackmon J; Rajpara A; Fraga G
Dermatol Online J; 2013 Sep; 19(9):19620. PubMed ID: 24050294
[TBL] [Abstract][Full Text] [Related]
20. A case of ductal sweat gland carcinoma connected to syringocystadenoma papilliferum arising in nevus sebaceus.
Ansai S; Koseki S; Hashimoto H; Hozumi Y; Kondo S
J Cutan Pathol; 1994 Dec; 21(6):557-63. PubMed ID: 7699123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
